Clinical trial
Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
NCT00115804 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00115804 |
|---|---|
| Title | Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia |
| Official title | An Open-Label Clinical Trial of Fluoxetine Treatment of Juvenile Primary Fibromyalgia Syndrome |
| Lead sponsor | University of Cincinnati, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Juvenile Primary Fibromyalgia Syndrome (JPFS), Fibromyalgia |
| Intervention type | Drug |
| Interventions | Fluoxetine |
| Enrollment | 6 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | Jun 27, 2005 |
| Last update posted | Feb 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: